Channels :: FRELIP Discovery

Author: Kellermann, Tracy

Quick Look
The development and validation of an LC-MS/MS method for the quantification of ertapenem in human plasma: application to paediatric XDR-TB case studies

Similar Items: The development and validation of an LC-MS/MS method for the quantification of ertapenem in human plasma: application to paediatric XDR-TB case studies

Quick Look
LC-MS/MS methods for the quantification of sulfasalazine and sulfapyridine in various matrices: application to a pharmacokinetic study
Quick Look
Evolution of XDR-TB and the associated proteome
Quick Look
Resistance to the novel nitroimidazole drug class in Mycobacterium tuberculosis
Quick Look
The antimycobacterial activity of phytocannabinoids
Quick Look
Mechanisms of resistance to new generation anti-TB drugs
Quick Look
Development of a drug discovery protocol through the expression of key mycothiol biosynthetic enzymes for Mycobacterium tuberculosis
Quick Look
Investigating novel variants associated with the isoniazid resistance phenotype in MDR-TB using whole genome sequencing
Quick Look
The development and validation of an LC-MS/MS method for the quantification of metformin in human plasma
Quick Look
Defining the role of efflux pump inhibitors on anti-TB drugs in Rifampicin resistant clinical Mycobacterium Tuberculosis isolates
Quick Look
A pharmacometric approach to optimal use of second line drugs for multidrug-resistant tuberculosis
Quick Look
The Development and Validation of a Direct LC-MS/MS Assay for the Determination of Tenofovir-diphosphate in Dried Blood Spots for the Analysis of Clinical Samples
Quick Look
The determination of β-endosulfan and endosulfan sulfate in human serum with dialkylphosphate metabolites as urinary markers using LC-MS/MS electrospray ionization
Quick Look
Determination of Rifapentine and 25-O-desacetyl Rifapentine from 100 µl human breastmilk by LC-MS/MS using protein precipitation and solid phase extraction
Quick Look
Evaluation of rapid low-cost colorimetric methods for diagnosis of multidrug-resistant tuberculosis in limited-resource settings
Quick Look
Accuracy and impact of the MTBDRplus v2 and MTBDRsl v2 line probe assays for the detection of first-line and second-line drug resistant tuberculosis
Quick Look
Pharmacokinetics and dosing rationale of Para-Aminosalicylic acid in children and the evaluation of the in vitro metabolism of Ethionamide, Terizidone and Para-aminosalicylic acid
Quick Look
Characterisation of phenotypic and genotypic resistance to new and re-purposed tuberculosis drugs in the Western Cape, South Africa
Quick Look
Pharmacokinetics of twice-daily versus once-daily dosing with granular slow-release para-aminosalicylic acid in adults on second-line anti-tuberculosis and antiretroviral treatment
Quick Look
Resistance to new tuberculosis drugs
Quick Look
Deciphering the physiology of drug tolerant and resistant Mycobacterium tuberculosis
Quick Look
Development and validation of liquid chromatography mass spectrometry (L/C/MS/MS) assay for the determination of plasma 4betahydroxycholestrol and cholesterol in HIV infected children in Africa
Quick Look
Factors affecting the activity of antimicrobial preservatives
Quick Look
Mass spectrometric identification of mycobacterium tuberculosis antigens in bronchoalveolar lavage fluid at the end of curative TB treatment.
Quick Look
Addressing critical knowledge gaps to improve and shorten multidrug-resistant tuberculosis treatment regimens in children